{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:16:23Z","timestamp":1785798983651,"version":"3.56.0"},"reference-count":282,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Foundation","doi-asserted-by":"publisher","award":["R01 CA166741"],"award-info":[{"award-number":["R01 CA166741"]}],"id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007048","name":"Mayo Foundation","doi-asserted-by":"publisher","award":["F30 CA183507"],"award-info":[{"award-number":["F30 CA183507"]}],"id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.bbamcr.2015.03.012","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T18:39:11Z","timestamp":1428259151000},"page":"1658-1671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment"],"prefix":"10.1016","volume":"1853","author":[{"given":"Cristina","family":"Correia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X. Wei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole D.","family":"Vincelette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.B.","family":"Knorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz S.","family":"Nowakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott H.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2015.03.012_bb0005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0010","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ceb.2006.10.008","article-title":"Apoptosis in the treatment of cancer: a promise kept?","volume":"18","author":"Meng","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrm2312","article-title":"Apoptosis: controlled demolition at the cellular level","volume":"9","author":"Taylor","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.biochem.68.1.383","article-title":"Mammalian caspases: structure, activation, substrates and functions during apoptosis","volume":"68","author":"Earnshaw","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.cr.7310028","article-title":"How the Bcl-2 family of proteins interact to regulate apoptosis","volume":"2","author":"van Delft","year":"2006","journal-title":"Cell Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","article-title":"The role of mitochondria in apoptosis","volume":"43","author":"Wang","year":"2009","journal-title":"Ann. Rev. Genet."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0035","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0092-8674(00)80085-9","article-title":"Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C","volume":"86","author":"Liu","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0040","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.biochem.73.011303.073706","article-title":"Cytochrome C-mediated apoptosis","volume":"73","author":"Jiang","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0045","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/emboj.2011.307","article-title":"Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases","volume":"30","author":"Strasser","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tibs.2013.12.006","article-title":"Many players in BCL-2 family affairs","volume":"39","author":"Moldoveanu","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chembiol.2013.10.009","article-title":"Death upon a kiss: mitochondrial outer membrane composition and organelle communication govern sensitivity to BAK\/BAX-dependent apoptosis","volume":"21","author":"Renault","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0065","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ceb.2005.09.001","article-title":"The mitochondrial death squad \u2014 hardened killers or innocent bystanders?","volume":"17","author":"Ekert","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.devcel.2011.06.017","article-title":"Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics","volume":"21","author":"Martinou","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0075","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrn3228","article-title":"Apoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology","volume":"13","author":"Hyman","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0080","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1126\/science.7878464","article-title":"Apoptosis in the pathogenesis and treatment of disease","volume":"267","author":"Thompson","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0085","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1126\/science.3874430","article-title":"Involvement of the bcl-2 gene in human follicular lymphoma","volume":"228","author":"Tsujimoto","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0090","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0095","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.275.5302.967","article-title":"Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype","volume":"275","author":"Rampino","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood-2006-06-026500","article-title":"Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas","volume":"109","author":"Mestre-Escorihuela","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0105","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0110","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.1059108","article-title":"Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death","volume":"292","author":"Wei","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0115","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1101\/gad.897601","article-title":"BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak","volume":"15","author":"Zong","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0120","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1128\/MCB.18.10.6083","article-title":"Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing","volume":"18","author":"Wang","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0125","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.molcel.2008.04.005","article-title":"To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions","volume":"30","author":"Dewson","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.molcel.2009.11.008","article-title":"Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices","volume":"36","author":"Dewson","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0135","doi-asserted-by":"crossref","first-page":"26027","DOI":"10.1074\/jbc.M113.490094","article-title":"Assembly of the Bak apoptotic pore: a critical role for the Bak protein alpha6 helix in the multimerization of homodimers during apoptosis","volume":"288","author":"Ma","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0140","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/srep00257","article-title":"Bak conformational changes induced by ligand binding: insight into BH3 domain binding and Bak homo-oligomerization","volume":"2","author":"Pang","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0145","doi-asserted-by":"crossref","first-page":"17614","DOI":"10.1074\/jbc.M110.113456","article-title":"Bax forms an oligomer via separate, yet interdependent, surfaces","volume":"285","author":"Zhang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0150","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cell.2012.12.031","article-title":"Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis","volume":"152","author":"Czabotar","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0155","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.molcel.2014.07.016","article-title":"Bak core and latch domains separate during activation, and freed core domains form symmetric homodimers","volume":"55","author":"Brouwer","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0160","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ceb.2005.10.001","article-title":"Life in the balance: how BH3-only proteins induce apoptosis","volume":"17","author":"Willis","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0165","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1101\/gad.14.16.2060","article-title":"tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c","volume":"14","author":"Wei","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0170","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.molcel.2005.02.003","article-title":"BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly","volume":"17","author":"Kuwana","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1535-6108(02)00127-7","article-title":"Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics","volume":"2","author":"Letai","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0180","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/ncb1499","article-title":"Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies","volume":"8","author":"Kim","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0185","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nature07396","article-title":"BAX activation is initiated at a novel interaction site","volume":"455","author":"Gavathiotis","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1074\/jbc.M113.505701","article-title":"Evaluation of the BH3-only protein Puma as a direct Bak activator","volume":"289","author":"Dai","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1083\/jcb.201102027","article-title":"Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization","volume":"194","author":"Dai","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0200","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.1190217","article-title":"BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program","volume":"330","author":"Ren","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0205","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/cdd.2011.100","article-title":"Can the analysis of BH3-only protein knockout mice clarify the issue of \u2018direct versus indirect\u2019 activation of Bax and Bak?","volume":"18","author":"Villunger","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0210","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20061552","article-title":"Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction","volume":"203","author":"Erlacher","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0215","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.molcel.2013.08.048","article-title":"BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response","volume":"51","author":"Sarosiek","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0220","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1074\/jbc.M110.167148","article-title":"BH3 domains other than Bim and Bid can directly activate Bax\/Bak","volume":"286","author":"Du","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0225","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nsmb.2563","article-title":"BID-induced structural changes in BAK promote apoptosis","volume":"20","author":"Moldoveanu","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0230","doi-asserted-by":"crossref","first-page":"E986","DOI":"10.1073\/pnas.1214313110","article-title":"Direct activation of full-length proapoptotic BAK","volume":"110","author":"Leshchiner","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0235","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.molcel.2010.10.019","article-title":"BH3-triggered structural reorganization drives the activation of proapoptotic BAX","volume":"40","author":"Gavathiotis","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0240","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.molcel.2009.09.030","article-title":"Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis","volume":"36","author":"Kim","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0245","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molcel.2006.08.020","article-title":"A stapled BID BH3 helix directly binds and activates BAX","volume":"24","author":"Walensky","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0250","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1133289","article-title":"Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak","volume":"315","author":"Willis","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0255","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","article-title":"Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function","volume":"17","author":"Chen","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0260","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.molcel.2011.10.001","article-title":"A unified model of mammalian BCL-2 protein family interactions at the mitochondria","volume":"44","author":"Llambi","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0265","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.chembiol.2013.06.007","article-title":"Multimodal interaction with BCL-2 family proteins underlies the proapoptotic activity of PUMA BH3","volume":"20","author":"Edwards","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0270","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1158\/0008-5472.CAN-13-0940","article-title":"Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance","volume":"73","author":"Dai","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0275","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1158\/0008-5472.CAN-12-2269","article-title":"Systems analysis of BCL2 protein family interactions establishes a model to predict responses to chemotherapy","volume":"73","author":"Lindner","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0280","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.celrep.2013.09.010","article-title":"BIM-mediated membrane insertion of the BAK pore domain is an essential requirement for apoptosis","volume":"5","author":"Weber","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0285","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/cdd.2013.4","article-title":"Targeting Bax interaction sites reveals that only homo-oligomerization sites are essential for its activation","volume":"20","author":"Peng","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0290","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1074\/jbc.M112.422204","article-title":"Direct interaction of Bax and Bak proteins with Bcl-2 homology domain 3 (BH3)-only proteins in living cells revealed by fluorescence complementation","volume":"288","author":"Vela","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0295","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.200905153","article-title":"The role of BH3-only protein Bim extends beyond inhibiting Bcl-2-like prosurvival proteins","volume":"186","author":"Merino","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0300","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/381335a0","article-title":"X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death","volume":"381","author":"Muchmore","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0305","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(00)00167-7","article-title":"Structure of Bax: coregulation of dimer formation and intracellular localization","volume":"103","author":"Suzuki","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0310","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.molcel.2006.10.014","article-title":"The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site","volume":"24","author":"Moldoveanu","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0315","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/357216a0","article-title":"The crystal structure of diphtheria toxin","volume":"357","author":"Choe","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0320","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0969-2126(97)00200-1","article-title":"A mechanism for toxin insertion into membranes is suggested by the crystal structure of the channel-forming domain of colicin E1","volume":"5","author":"Elkins","year":"1997","journal-title":"Structure"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0325","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pbiomolbio.2004.01.009","article-title":"Pore-forming protein toxins: from structure to function","volume":"88","author":"Parker","year":"2005","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0330","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/sj.emboj.7600675","article-title":"Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis","volume":"24","author":"Annis","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0335","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.bpj.2010.08.068","article-title":"Pores formed by Baxalpha5 relax to a smaller size and keep at equilibrium","volume":"99","author":"Fuertes","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0340","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1742-4658.2006.05123.x","article-title":"Peptides corresponding to helices 5 and 6 of Bax can independently form large lipid pores","volume":"273","author":"Garcia-Saez","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0345","doi-asserted-by":"crossref","first-page":"17379","DOI":"10.1073\/pnas.0807764105","article-title":"Structure of transmembrane pore induced by Bax-derived peptide: evidence for lipidic pores","volume":"105","author":"Qian","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0350","doi-asserted-by":"crossref","first-page":"E4076","DOI":"10.1073\/pnas.1415142111","article-title":"Apoptotic pore formation is associated with in-plane insertion of Bak or Bax central helices into the mitochondrial outer membrane","volume":"111","author":"Westphal","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0355","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1074\/jbc.M708814200","article-title":"BIM and tBID are not mechanistically equivalent when assisting BAX to permeabilize bilayer membranes","volume":"283","author":"Terrones","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0360","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.1074\/jbc.M110.165852","article-title":"Reconstitution of proapoptotic BAK function in liposomes reveals a dual role for mitochondrial lipids in the BAK-driven membrane permeabilization process","volume":"286","author":"Landeta","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0365","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","article-title":"Apoptosis: a link between cancer genetics and chemotherapy","volume":"108","author":"Johnstone","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0370","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/excr.2000.4838","article-title":"Induction of apoptosis by cancer chemotherapy","volume":"256","author":"Kaufmann","year":"2000","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0375","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.1090072","article-title":"p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa","volume":"302","author":"Villunger","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0380","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ccr.2005.02.008","article-title":"Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy","volume":"7","author":"Tan","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0385","first-page":"3620","article-title":"Mechanisms of Taxol-induced cell death are concentration dependent","volume":"58","author":"Torres","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0390","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1172\/JCI35437","article-title":"Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic","volume":"118","author":"Cragg","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0395","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0606176103","article-title":"Bim and Bad mediate imatinib-induced killing of Bcr\/Abl+leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic","volume":"103","author":"Kuroda","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0400","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1200\/JCO.1999.17.9.2941","article-title":"Dysregulation of apoptosis in cancer","volume":"17","author":"Reed","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0405","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/carcin\/bgh283","article-title":"Apoptosis in the development and treatment of cancer","volume":"26","author":"Gerl","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0410","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(02)01036-X","article-title":"Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane","volume":"111","author":"Kuwana","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0415","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2006.03.027","article-title":"Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members","volume":"9","author":"Certo","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0420","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1172\/JCI28281","article-title":"Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737","volume":"117","author":"Del Gaizo Moore","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0425","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ccr.2007.07.001","article-title":"BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents","volume":"12","author":"Deng","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0430","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2012.08.038","article-title":"Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML","volume":"151","author":"Vo","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0435","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.1206727","article-title":"Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy","volume":"334","author":"Ni Chonghaile","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0440","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1073\/pnas.88.9.3671","article-title":"Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1","volume":"88","author":"Smiley","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0445","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1083\/jcb.200904049","article-title":"MCL-1-dependent leukemia cells are more sensitive to chemotherapy than BCL-2-dependent counterparts","volume":"187","author":"Brunelle","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0450","doi-asserted-by":"crossref","first-page":"12895","DOI":"10.1073\/pnas.0914878107","article-title":"Heightened mitochondrial priming is the basis for apoptotic hypersensitivity of CD4+ CD8+ thymocytes","volume":"107","author":"Ryan","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0455","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","article-title":"Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia","volume":"4","author":"Pan","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0460","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.118.118","article-title":"A phase 2 study of ABT-199 (GDC-0199) in patients with acute myelogenous leukemia (AML)","volume":"124","author":"Konopleva","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0465","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0092-8674(85)80070-2","article-title":"Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18","volume":"41","author":"Bakhshi","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0092-8674(86)90362-4","article-title":"Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2\/immunoglobulin transcript resulting from the t(14;18) translocation","volume":"47","author":"Cleary","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0475","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/335440a0","article-title":"Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells","volume":"335","author":"Vaux","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0480","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0485","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1242\/jcs.006197","article-title":"The tail-anchoring domain of Bfl1 and HCCS1 targets mitochondrial membrane permeability to induce apoptosis","volume":"120","author":"Ko","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0490","doi-asserted-by":"crossref","first-page":"30257","DOI":"10.1074\/jbc.M109.040824","article-title":"C-terminal residues regulate localization and function of the antiapoptotic protein Bfl-1","volume":"284","author":"Brien","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0495","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biocel.2014.11.015","article-title":"Role of the pro-survival molecule Bfl-1 in melanoma","volume":"59","author":"Hind","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0500","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1038\/cddis.2012.178","article-title":"The restricted binding repertoire of Bcl-B leaves Bim as the universal BH3-only prosurvival Bcl-2 protein antagonist","volume":"3","author":"Rautureau","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0505","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1101\/gad.1304105","article-title":"Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins","volume":"19","author":"Willis","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0510","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/sj.onc.1210771","article-title":"Bfl-1\/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist","volume":"27","author":"Simmons","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0515","doi-asserted-by":"crossref","first-page":"18311","DOI":"10.1074\/jbc.M109.004770","article-title":"Context-dependent Bcl-2\/Bak interactions regulate lymphoid cell apoptosis","volume":"284","author":"Dai","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0520","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.1106114","article-title":"Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells","volume":"307","author":"Opferman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0525","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1182\/blood-2008-05-159145","article-title":"Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function","volume":"113","author":"Steimer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0530","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ncb2488","article-title":"Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration","volume":"14","author":"Perciavalle","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0535","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1101\/gad.182980.111","article-title":"Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia","volume":"26","author":"Glaser","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0540","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1101\/gad.215855.113","article-title":"Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction","volume":"27","author":"Wang","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0545","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/febs.13188","article-title":"Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy","volume":"282","author":"Sochalska","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0550","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1182\/blood-2013-08-519470","article-title":"Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity","volume":"123","author":"Rooswinkel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0555","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature03098","article-title":"Intrinsic tumour suppression","volume":"432","author":"Lowe","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0560","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/348331a0","article-title":"Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2","volume":"348","author":"Strasser","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0565","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1128\/MCB.21.15.5063-5070.2001","article-title":"Apoptosis triggered by myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis","volume":"21","author":"Eischen","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0570","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/359554a0","article-title":"Cooperative interaction between c-myc and bcl-2 proto-oncogenes","volume":"359","author":"Fanidi","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0575","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1038\/onc.2008.307","article-title":"Bcl-2 family proteins and cancer","volume":"27","author":"Yip","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0580","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2007-09-078162","article-title":"Bcl-2-family proteins and hematologic malignancies: history and future prospects","volume":"111","author":"Reed","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0585","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.imlet.2013.09.015","article-title":"Reprogramming cell death: BCL2 family inhibition in hematological malignancies","volume":"155","author":"Scarfo","year":"2013","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0590","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2141.1994.tb04984.x","article-title":"The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia","volume":"88","author":"Maung","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0595","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0609.1999.tb01112.x","article-title":"Haematopoietic response and bcl-2 expression in patients with acute myeloid leukaemia","volume":"62","author":"Bincoletto","year":"1999","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0600","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1182\/blood.V91.3.991.991_991_1000","article-title":"Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse","volume":"91","author":"Kaufmann","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0605","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0610","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1128\/MCB.20.5.1886-1896.2000","article-title":"Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway","volume":"20","author":"Breitschopf","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0615","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1074\/jbc.M111.312694","article-title":"Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis","volume":"287","author":"Niture","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0620","doi-asserted-by":"crossref","first-page":"44542","DOI":"10.1074\/jbc.M111.275073","article-title":"Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis","volume":"286","author":"Niture","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0625","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1073\/pnas.92.10.4507","article-title":"Inactivation of Bcl-2 by phosphorylation","volume":"92","author":"Haldar","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0630","first-page":"1253","article-title":"Taxol induces bcl-2 phosphorylation and death of prostate cancer cells","volume":"56","author":"Haldar","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0635","first-page":"130","article-title":"Raf-1\/bcl-2 phosphorylation: a step from microtubule damage to cell death","volume":"57","author":"Blagosklonny","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0640","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.molcel.2008.06.001","article-title":"JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy","volume":"30","author":"Wei","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0645","first-page":"1609","article-title":"Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells","volume":"58","author":"Haldar","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0650","doi-asserted-by":"crossref","first-page":"21661","DOI":"10.1074\/jbc.M906893199","article-title":"Phosphorylation of Bcl-2 protein by CDC2 kinase during G2\/M phases and its role in cell cycle regulation","volume":"275","author":"Furukawa","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0655","doi-asserted-by":"crossref","first-page":"25238","DOI":"10.1074\/jbc.272.40.25238","article-title":"Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase\/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1","volume":"272","author":"Maundrell","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0660","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1073\/pnas.96.7.3775","article-title":"Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis","volume":"96","author":"Srivastava","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0665","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1128\/MCB.18.6.3509","article-title":"Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase","volume":"18","author":"Srivastava","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0670","doi-asserted-by":"crossref","first-page":"21353","DOI":"10.1074\/jbc.M511052200","article-title":"Bcl-2 phosphorylation by p38 MAPK: identification of target sites and biologic consequences","volume":"281","author":"De Chiara","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0675","doi-asserted-by":"crossref","first-page":"25436","DOI":"10.1074\/jbc.273.39.25436","article-title":"A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis","volume":"273","author":"Ruvolo","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0680","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1038\/sj.onc.1207698","article-title":"Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt","volume":"23","author":"Asnaghi","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0685","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/MCB.00882-09","article-title":"Cyclin-dependent kinase 1-mediated Bcl-xL\/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis","volume":"30","author":"Terrano","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0690","doi-asserted-by":"crossref","first-page":"39193","DOI":"10.1074\/jbc.M112.391854","article-title":"Cyclin-dependent kinase-1 (Cdk1)\/cyclin B1 dictates cell fate after mitotic arrest via phosphoregulation of antiapoptotic Bcl-2 proteins","volume":"287","author":"Sakurikar","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0695","doi-asserted-by":"crossref","first-page":"18984","DOI":"10.1074\/jbc.273.30.18984","article-title":"Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis","volume":"273","author":"Ling","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0700","doi-asserted-by":"crossref","first-page":"30777","DOI":"10.1074\/jbc.273.46.30777","article-title":"Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest","volume":"273","author":"Scatena","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0705","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/MCB.19.12.8469","article-title":"BCL-2 is phosphorylated and inactivated by an ASK1\/Jun N-terminal protein kinase pathway normally activated at G(2)\/M","volume":"19","author":"Yamamoto","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0710","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.emboj.7600104","article-title":"Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis","volume":"23","author":"Bassik","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0715","doi-asserted-by":"crossref","first-page":"11671","DOI":"10.1074\/jbc.272.18.11671","article-title":"Bcl-2 phosphorylation required for anti-apoptosis function","volume":"272","author":"Ito","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0720","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1073\/pnas.97.4.1578","article-title":"Survival function of ERK1\/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases","volume":"97","author":"Deng","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0725","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1073\/pnas.2533920100","article-title":"Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions","volume":"101","author":"Deng","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0730","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1128\/MCB.01647-05","article-title":"Bcl2's flexible loop domain regulates p53 binding and survival","volume":"26","author":"Deng","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0735","doi-asserted-by":"crossref","first-page":"40209","DOI":"10.1074\/jbc.M404056200","article-title":"Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation","volume":"279","author":"Jin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0740","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1073\/pnas.041619798","article-title":"Solution structure of the antiapoptotic protein bcl-2","volume":"98","author":"Petros","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0745","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/cr.2010.149","article-title":"Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX","volume":"21","author":"Ku","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0750","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1038\/sj.onc.1210396","article-title":"Nuclear colocalization and interaction between bcl-xL and cdk1(cdc2) during G2\/M cell-cycle checkpoint","volume":"26","author":"Schmitt","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0755","doi-asserted-by":"crossref","first-page":"35517","DOI":"10.1074\/jbc.M805019200","article-title":"Identification of the major phosphorylation site in Bcl-xL induced by microtubule inhibitors and analysis of its functional significance","volume":"283","author":"Upreti","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0760","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/MCB.00620-06","article-title":"Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization","volume":"27","author":"Ding","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0765","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.molcel.2006.02.009","article-title":"Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1","volume":"21","author":"Maurer","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0770","doi-asserted-by":"crossref","first-page":"18407","DOI":"10.1074\/jbc.M610010200","article-title":"Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1","volume":"282","author":"Kobayashi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0775","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.leu.2403275","article-title":"PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation","volume":"18","author":"Jiffar","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0780","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1158\/0008-5472.CAN-08-0579","article-title":"Down-regulation of myeloid cell leukemia-1 through inhibiting Erk\/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer","volume":"68","author":"Ding","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0785","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1182\/blood-2014-03-563296","article-title":"Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56delta stabilizes its antiapoptotic activity","volume":"124","author":"Low","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0790","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3324\/haematol.2012.066209","article-title":"Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL Rituximab-CHOP Consortium Program Study","volume":"98","author":"Visco","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0795","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1182\/blood.V79.1.229.229","article-title":"Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgkin's lymphomas","volume":"79","author":"Tanaka","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0800","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/j.1460-2075.1988.tb02791.x","article-title":"Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma","volume":"7","author":"Seto","year":"1988","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0805","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":"Double-hit B-cell lymphomas","volume":"117","author":"Aukema","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0810","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0815","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0820","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0825","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/leu.2011.378","article-title":"BCL2 mutations in diffuse large B-cell lymphoma","volume":"26","author":"Schuetz","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0830","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2014-04-516815","article-title":"Transformed follicular non-Hodgkin lymphoma","volume":"125","author":"Casulo","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0835","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1182\/asheducation-2009.1.532","article-title":"The incidence, natural history, biology, and treatment of transformed lymphomas","author":"Bernstein","year":"2009","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0840","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1200\/JCO.2010.32.7577","article-title":"Transformation of indolent B-cell lymphomas","volume":"29","author":"Montoto","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0845","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0850","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","article-title":"Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma","volume":"121","author":"Green","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0855","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0860","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/10428199309145877","article-title":"Somatic point mutations in the translocated bcl-2 genes of non-Hodgkin's lymphoGas and lymphocytic leukemias: implications for mechanisms of tumor progression","volume":"10","author":"Reed","year":"1993","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0865","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/349254a0","article-title":"Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)","volume":"349","author":"McDonnell","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0870","doi-asserted-by":"crossref","first-page":"17682","DOI":"10.1074\/jbc.M110.189092","article-title":"Noxa\/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells","volume":"286","author":"Smith","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0875","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1182\/blood-2014-04-571786","article-title":"BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma","volume":"125","author":"Correia","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0880","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1016\/j.febslet.2008.09.028","article-title":"Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim","volume":"582","author":"Herman","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0885","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/emboj\/17.4.1029","article-title":"The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4","volume":"17","author":"Huang","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0890","doi-asserted-by":"crossref","first-page":"20415","DOI":"10.1074\/jbc.274.29.20415","article-title":"NH2-terminal BH4 domain of Bcl-2 is functional for heterodimerization with Bax and inhibition of apoptosis","volume":"274","author":"Hirotani","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0895","doi-asserted-by":"crossref","first-page":"e73386","DOI":"10.1371\/journal.pone.0073386","article-title":"Alpha-helical destabilization of the Bcl-2-BH4-domain peptide abolishes its ability to inhibit the IP3 receptor","volume":"8","author":"Monaco","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0900","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.molcel.2015.01.014","article-title":"Inhibition of pro-apoptotic BAX by a noncanonical interaction mechanism","volume":"57","author":"Barclay","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0905","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1158\/0008-5472.CAN-06-2419","article-title":"G-rich proto-oncogenes are targeted for genomic instability in B-cell lymphomas","volume":"67","author":"Duquette","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0910","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminhematol.2008.07.003","article-title":"Treatment of follicular non-Hodgkin's lymphoma: the old and the new","volume":"45","author":"Friedberg","year":"2008","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0915","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","article-title":"Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource","volume":"31","author":"Link","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0920","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1021\/jm030190z","article-title":"Discovery, characterization, and structure\u2013activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte\/leukemia-2 proteins","volume":"46","author":"Kitada","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0925","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1126\/science.274.5292.1531","article-title":"Discovering high-affinity ligands for proteins: SAR by NMR","volume":"274","author":"Shuker","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0930","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nrd2658","article-title":"BCL-2 family antagonists for cancer therapy","volume":"7","author":"Lessene","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0935","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1158\/1535-7163.MCT-13-0058","article-title":"BH3 mimetics: status of the field and new developments","volume":"12","author":"Billard","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0940","doi-asserted-by":"crossref","first-page":"e1590","DOI":"10.1038\/cddis.2014.561","article-title":"Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)","volume":"6","author":"Leverson","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0945","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pharmthera.2014.08.003","article-title":"Small molecule Mcl-1 inhibitors for the treatment of cancer","volume":"145","author":"Belmar","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0950","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0006-2952(02)01148-6","article-title":"Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs","volume":"64","author":"Baell","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0955","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","article-title":"The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized","volume":"10","author":"van Delft","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0960","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1021\/jm060460o","article-title":"Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins","volume":"49","author":"Wang","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0965","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1021\/jm701358v","article-title":"Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins","volume":"51","author":"Tang","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0970","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1182\/blood-2007-12-129833","article-title":"Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma","volume":"111","author":"Paoluzzi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0975","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1476-4598-7-20","article-title":"Preclinical studies of apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in follicular small cleaved cell lymphoma model","volume":"7","author":"Arnold","year":"2008","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0980","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fonc.2011.00028","article-title":"An optically pure apogossypolone derivative as potent pan-active inhibitor of anti-apoptotic bcl-2 family proteins","volume":"1","author":"Wei","year":"2011","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0985","doi-asserted-by":"crossref","first-page":"19512","DOI":"10.1073\/pnas.0709443104","article-title":"Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis","volume":"104","author":"Nguyen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0990","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2006-07-034173","article-title":"The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak","volume":"109","author":"Perez-Galan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb0995","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/asheducation-2005.1.226","article-title":"Modulating the bcl-2 family of apoptosis suppressors for potential therapeutic benefit in cancer","author":"Shore","year":"2005","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1000","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/cdd.2008.137","article-title":"Bcl-2 inhibitors: small molecules with a big impact on cancer therapy","volume":"16","author":"Vogler","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1005","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bcp.2011.11.027","article-title":"Identification of dual mTORC1 and mTORC2 inhibitors in melanoma cells: prodigiosin vs. obatoclax","volume":"83","author":"Espona-Fiedler","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1010","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1015","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1158\/0008-5472.CAN-07-5836","article-title":"ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor","volume":"68","author":"Tse","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1020","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/jm061152t","article-title":"Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL","volume":"50","author":"Bruncko","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1025","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","article-title":"Programmed anuclear cell death delimits platelet life span","volume":"128","author":"Mason","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1030","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1084\/jem.20110750","article-title":"Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets","volume":"208","author":"Josefsson","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1040","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/leu.2013.216","article-title":"The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma","volume":"28","author":"Touzeau","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1045","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1182\/blood-2009-07-233304","article-title":"Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1","volume":"115","author":"Yecies","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccr.2006.10.006","article-title":"Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia","volume":"10","author":"Konopleva","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.seminhematol.2014.05.008","article-title":"Targeting BCL2 for the treatment of lymphoid malignancies","volume":"51","author":"Anderson","year":"2014","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1060","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S1470-2045(10)70261-8","article-title":"Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity","volume":"11","author":"Wilson","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1065","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1200\/JCO.2011.34.7898","article-title":"Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease","volume":"30","author":"Roberts","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1070","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ccr.2013.06.002","article-title":"Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer","volume":"24","author":"Vaillant","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1075","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2014-05-574566","article-title":"ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia","volume":"124","author":"Peirs","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1080","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.18632\/oncotarget.1925","article-title":"The BCL2 inhibitor ABT-199 significantly enhances imatinib-induced cell death in chronic myeloid leukemia progenitors","volume":"5","author":"Ko","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1085","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1158\/1078-0432.CCR-14-1134","article-title":"Inhibition of NANOG\/NANOGP8 downregulates MCL-1 in colorectal cancer cells and enhances the therapeutic efficacy of BH3 mimetics","volume":"20","author":"Mattoo","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1090","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.1789.1789","article-title":"The single-agent Bcl-2 inhibitor ABT-199 (GDC-0199) in patients with relapsed\/refractory (R\/R) non-Hodgkin lymphoma (NHL): responses observed in all mantle cell lymphoma (MCL) patients","volume":"122","author":"Davids","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1095","article-title":"Bcl-2 inhibitor ABT-199 (GDC-0199) monotherapy shows anti-tumor activity including complete remissions in high-risk relapsed\/refractory (R\/R) chronic lymphoma leukemia (CLL) and small lymphocytic lymphoma (SLL)","volume":"122","author":"Seymour","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1100","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.325.325","article-title":"Determination of recommended phase 2 dose OF ABT-199 (GDC-0199) combined with rituximab\u00ae in patients with relapse\/refractory (R\/R) chronic lymphocytic leukemia (CLL)","volume":"124","author":"Roberts","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1105","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.4687.4687","article-title":"Preliminary results of a phase 1b study (GP28331) combining GDC-0199 (ABT-199) and obinutuzumab in patients with relapsed\/refractory or previously untreated chronic lymphocytic leukemia","volume":"124","author":"Flinn","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1110","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.3337.3337","article-title":"Preliminary results of a phase 1b study (GO28440) combining GDC-0199 (ABT-199) with bendamustine\/rituximab in patients with relapsed\/refractory or previously untreated chronic lymphocytic leukemia","volume":"124","author":"Salles","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1115","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.1722.1722","article-title":"The BCL-2 inhibitor ABT-199 (GDC-0199) in combination with bendamustine and rituximab in patients with relapsed or refractory non-Hodgkin's lymphoma","volume":"124","author":"de Vos","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0748-7983(96)90176-6","article-title":"Bcl-2 expression in malignant melanoma and its prognostic significance","volume":"22","author":"Grover","year":"1996","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1125","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/path.1711770206","article-title":"Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas","volume":"177","author":"Jiang","year":"1995","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1130","first-page":"1191","article-title":"Bcl-2 protein expression and long-term survival in breast cancer","volume":"145","author":"Joensuu","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1135","first-page":"6940","article-title":"Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer","volume":"52","author":"McDonnell","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1140","first-page":"1103","article-title":"Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma","volume":"1","author":"Sinicrope","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1097-0215(19960422)69:2<100::AID-IJC5>3.0.CO;2-4","article-title":"Bcl-2\/bax mRNA expression ratio as prognostic factor in low-grade urinary bladder cancer","volume":"69","author":"Gazzaniga","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1150","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1242\/jcs.095976","article-title":"Downregulation of BCL2 by miRNAs augments drug-induced apoptosis\u2014a combined computational and experimental approach","volume":"125","author":"Singh","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1155","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/cdd.2014.176","article-title":"Transformer 2beta and miR-204 regulate apoptosis through competitive binding to 3\u2032 UTR of BCL2 mRNA","volume":"22","author":"Kuwano","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1160","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1210\/en.2006-0502","article-title":"Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak","volume":"147","author":"Castilla","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1165","doi-asserted-by":"crossref","first-page":"11778","DOI":"10.18632\/oncotarget.2634","article-title":"Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation","volume":"5","author":"Keitel","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1170","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jhep.2009.12.024","article-title":"The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma","volume":"52","author":"Shimizu","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1175","first-page":"955","article-title":"Let-7c sensitizes acquired cisplatin-resistant A549 cells by targeting ABCC2 and Bcl-XL","volume":"68","author":"Zhan","year":"2013","journal-title":"Pharmazie"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1180","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1172\/JCI66553","article-title":"CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia","volume":"123","author":"Chen","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1185","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.3390\/molecules171214733","article-title":"MicroRNA miR-491-5p targeting both TP53 and Bcl-XL induces cell apoptosis in SW1990 pancreatic cancer cells through mitochondria mediated pathway","volume":"17","author":"Guo","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1190","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/ijc.25143","article-title":"Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells","volume":"127","author":"Nakano","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1195","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.0902-4441.2003.00201.x","article-title":"Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients","volume":"72","author":"Gutierrez-Castellanos","year":"2004","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1200","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/blood.V91.9.3379","article-title":"Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses","volume":"91","author":"Kitada","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1205","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1517\/13543784.2011.609167","article-title":"Targeting Mcl-1 for the therapy of cancer","volume":"20","author":"Quinn","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1210","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.leu.2403784","article-title":"Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival","volume":"19","author":"Wuilleme-Toumi","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1215","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.3800750","article-title":"Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma","volume":"20","author":"Zhuang","year":"2007","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1220","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1158\/0008-5472.CAN-06-1788","article-title":"Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer","volume":"67","author":"Ding","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1225","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1349-7006.2002.tb01289.x","article-title":"Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas","volume":"93","author":"Shigemasa","year":"2002","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1230","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1023\/A:1011112227044","article-title":"Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer","volume":"12","author":"Backus","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1235","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/jso.21344","article-title":"Prognostic role of myeloid cell leukemia-1 protein (Mcl-1) expression in human gastric cancer","volume":"100","author":"Likui","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1240","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2005.09.010","article-title":"Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy","volume":"44","author":"Sieghart","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1245","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/1947601910371978","article-title":"MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells","volume":"1","author":"Steele","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08646","article-title":"Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival","volume":"463","author":"Schwickart","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1255","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1038\/onc.2012.318","article-title":"MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R","volume":"32","author":"Gong","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1260","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.bbrc.2009.07.143","article-title":"MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer","volume":"388","author":"Crawford","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1265","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature09779","article-title":"Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7","volume":"471","author":"Wertz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1270","doi-asserted-by":"crossref","first-page":"239","DOI":"10.18632\/oncotarget.242","article-title":"Mcl-1 ubiquitination and destruction","volume":"2","author":"Inuzuka","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1275","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1172\/JCI9940","article-title":"Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression","volume":"107","author":"Epling-Burnette","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1280","first-page":"1093","article-title":"Bcl-w is expressed in a majority of infiltrative gastric adenocarcinomas and suppresses the cancer cell death by blocking stress-activated protein kinase\/c-Jun NH2-terminal kinase activation","volume":"63","author":"Lee","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1285","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1038\/sj.onc.1203729","article-title":"Bcl-w is an important determinant of damage-induced apoptosis in epithelia of small and large intestine","volume":"19","author":"Pritchard","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1290","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1054\/bjoc.1999.0897","article-title":"Bcl-w expression in colorectal adenocarcinoma","volume":"82","author":"Wilson","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1295","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1593\/neo.04535","article-title":"Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets","volume":"7","author":"Hoelzinger","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1300","doi-asserted-by":"crossref","first-page":"e68030","DOI":"10.1371\/journal.pone.0068030","article-title":"Bcl-w enhances mesenchymal changes and invasiveness of glioblastoma cells by inducing nuclear accumulation of beta-catenin","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1305","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1158\/0008-5472.CAN-3263-2","article-title":"Alteration in copy numbers of genes as a mechanism for acquired drug resistance","volume":"64","author":"Yasui","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1310","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.leukres.2008.01.016","article-title":"Altered gene expression in busulfan-resistant human myeloid leukemia","volume":"32","author":"Valdez","year":"2008","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1315","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3892\/or.2013.2482","article-title":"miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w","volume":"30","author":"Cao","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1320","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/onc.2011.340","article-title":"MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1","volume":"31","author":"Xu","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1325","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3892\/etm.2011.428","article-title":"miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w","volume":"3","author":"Shen","year":"2012","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1330","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1742-4658.2010.07997.x","article-title":"microRNA-203 suppresses bladder cancer development by repressing bcl-w expression","volume":"278","author":"Bo","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1335","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbrc.2008.07.154","article-title":"miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines","volume":"375","author":"Lin","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1340","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.gene.2008.12.002","article-title":"The Bcl-w promoter is activated by beta-catenin\/TCF4 in human colorectal carcinoma cells","volume":"432","author":"Lapham","year":"2009","journal-title":"Gene"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1345","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1046\/j.1365-2141.2003.04121.x","article-title":"Abnormal expression of apoptosis-related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma","volume":"120","author":"Nagy","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1350","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1158\/1535-7163.MCT-05-0146","article-title":"Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures","volume":"4","author":"Mahadevan","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1355","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1172\/JCI29401","article-title":"Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes","volume":"116","author":"Piva","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1360","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ijc.20614","article-title":"High expression of bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia","volume":"113","author":"Morales","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1365","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/sj.cdd.4401684","article-title":"Constitutive proteasome-mediated turnover of Bfl-1\/A1 and its processing in response to TNF receptor activation in FL5.12 pro-B cells convert it into a prodeath factor","volume":"12","author":"Kucharczak","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1370","doi-asserted-by":"crossref","first-page":"13663","DOI":"10.1074\/jbc.M600266200","article-title":"The stability and anti-apoptotic function of A1 are controlled by its C terminus","volume":"281","author":"Herold","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1375","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1101\/gad.13.4.382","article-title":"The prosurvival Bcl-2 homolog Bfl-1\/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis","volume":"13","author":"Zong","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1380","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.4049\/jimmunol.173.10.5963","article-title":"Eosinophil adhesion to cholinergic IMR-32 cells protects against induced neuronal apoptosis","volume":"173","author":"Morgan","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1385","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/cdd.2011.158","article-title":"BCL2A1: the underdog in the BCL2 family","volume":"19","author":"Vogler","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1390","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1158\/1078-0432.CCR-07-1955","article-title":"Bcl-B expression in human epithelial and nonepithelial malignancies","volume":"14","author":"Krajewska","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1395","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1038\/onc.2013.99","article-title":"Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B","volume":"32","author":"van de Kooij","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1400","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1405","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.chembiol.2004.02.020","article-title":"Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L)","volume":"11","author":"Becattini","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbamcr.2015.03.012_bb1410","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1158\/0008-5472.CAN-05-3691","article-title":"Antiangiogenic effect of TW37, a small-molecule inhibitor of Bcl-2","volume":"66","author":"Zeitlin","year":"2006","journal-title":"Cancer Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488915000981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488915000981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T10:21:16Z","timestamp":1651659676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488915000981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":282,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0167488915000981"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2015.03.012","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging understanding of Bcl-2 biology: Implications for neoplastic progression and treatment","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2015.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}